Genetic engineering of vascular grafts to resist disease

Disclosed are methods for treating a vascular graft that include introducing an effective amount of at least one nucleic acid encoding at least one agent that increases activated protein C (APC), expressing the agent in the cells; and increasing the APC sufficient to treat the blood vessel. Also pro...

Full description

Saved in:
Bibliographic Details
Main Authors RADE JEFFREY J, KIM ANTONY Y, SOHN RICHARD H
Format Patent
LanguageEnglish
Published 06.06.2002
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are methods for treating a vascular graft that include introducing an effective amount of at least one nucleic acid encoding at least one agent that increases activated protein C (APC), expressing the agent in the cells; and increasing the APC sufficient to treat the blood vessel. Also provided are vascular grafts engineered to resist early and/or late graft failure.
Bibliography:Application Number: US20010863803